We believe in delivering innovative and actionable pricing and reimbursement solutions to our clients with both energy and passion.
Our global P&R team consists of multi-disciplinary expert consultants and analysts that have conducted pricing and reimbursement analysis across a range of therapy areas. We can bring into a project with you both decades of experience, as well as our understanding of multiple analogues in most disease areas.
Our core strength is delivering high-quality qualitative research at all stages of product development. We routinely conduct P&R research in the US and Europe, as well as both developed and emerging markets all over the globe (Link to network map). We base our recommendations on in-depth research of secondary materials, analysis of relevant analogues, as well as qualitative and semi-quantitative primary research and price modelling.
We underpin our primary research with a personally managed network of payers, payer advisers, HTA reviewers, health-policy-makers and price sensitive customers across 40 markets worldwide.